Document Detail

Ergotamine treatment during pregnancy and a higher rate of low birthweight and preterm birth.
MedLine Citation:
PMID:  17506783     Owner:  NLM     Status:  MEDLINE    
AIMS: Previously the association between oral ergotamine treatment during pregnancy and gestational age at delivery, birthweight, the rate of preterm birth and low birthweight has not been studied.
METHODS: Newborn infants without congenital abnormalities born to mothers with or without ergotamine treatment during pregnancy were evaluated in the population-based data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities between 1980 and 1996.
RESULTS: Of 38,151 newborn infants with medically recorded gestational age and birth weight, 77 were born to mothers who had received ergotamine treatment during pregnancy. A statistically significant decrease was found in the mean gestational age (0.7 weeks) and birth weight (196 g) among exposed relative to unexposed infants, though these differences were not obstetrically significant. However, there was a significant increase in the proportion of low birthweight newborns (16.4% vs. 5.7%) and preterm births (16.4% vs. 9.2%) after the use of ergotamine during pregnancy. The effect of ergotamine was more obvious in male newborn infants, particularly after treatment in the third trimester.
CONCLUSIONS: The association between low birthweight and/or preterm birth and ergotamine treatment may be connected with the effect of ergotamine on the placenta of pregnant women.
Ferenc Bánhidy; Nándor Acs; Erzsébet Puhó; Andrew E Czeizel
Related Documents :
9236823 - The aetiology of low birthweight in a rural area of tanzania.
1879623 - Assessment of gestational age: modification of a simplified method.
9240893 - Malignant b-cell lymphoma in an infant with severe combined immunodeficiency with short...
Publication Detail:
Type:  Journal Article     Date:  2007-05-15
Journal Detail:
Title:  British journal of clinical pharmacology     Volume:  64     ISSN:  0306-5251     ISO Abbreviation:  Br J Clin Pharmacol     Publication Date:  2007 Oct 
Date Detail:
Created Date:  2007-09-20     Completed Date:  2008-03-14     Revised Date:  2013-06-06    
Medline Journal Info:
Nlm Unique ID:  7503323     Medline TA:  Br J Clin Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  510-6     Citation Subset:  IM    
Second Department of Obstetrics & Gynecology, Semmelweis University, School of Medicine, Budapest, Hungary.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Ergotamine / adverse effects,  pharmacology*
Infant, Newborn
Infant, Small for Gestational Age*
Obstetric Labor, Premature / chemically induced*
Pregnancy Complications / drug therapy*
Vasoconstrictor Agents / adverse effects*
Reg. No./Substance:
0/Vasoconstrictor Agents; 113-15-5/Ergotamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Risk of congenital anomalies in pregnant users of statin drugs.
Next Document:  Detecting signals of drug-drug interactions in a spontaneous reports database.